Medwise AI

Medwise AI is a digital health company that provides an AI-powered, customizable search platform for healthcare professionals to access clinical information at the point of care. Founded in 2019 and headquartered in Leeds, UK, the company's mission is to improve workforce productivity and patient care by reducing the time clinicians spend searching for information. An independent evaluation showed the tool can save two and a half minutes during a typical ten-minute GP appointment.

The company was co-founded by Dr. Keith Tsui (CEO) and Luis Ulloa (CTO). Dr. Tsui is a medical doctor with a background in improving NHS productivity and clinical AI product management, having previously worked at Huma and graduated from the University of Cambridge. His experience on the front lines, often resorting to Google for urgent information, inspired the creation of a more reliable and efficient search tool. Luis Ulloa has over a decade of experience in applied AI and Natural Language Processing (NLP), previously working at Facebook's AI Lab and co-founding Bloomsbury AI, which was acquired by Facebook.

The platform utilizes NLP to provide concise, evidence-based answers from trusted global, national, and local clinical guidelines, academic journals, and local policy documents. This integration of local and national guidelines is a key differentiator, particularly within the UK's NHS. Healthcare organizations can customize the platform to their specific needs, integrating their own documents and using analytics to identify information gaps among their staff. Medwise AI operates on a B2B SaaS model, partnering with healthcare organizations like NHS Integrated Care Systems (ICS), telemedicine providers, and potentially pharmaceutical companies. The company has secured multiple rounds of funding, including over £1 million from Collaborative R&D grants via Innovate UK and a seed round of over £1 million led by Finance Yorkshire with participation from investors like StartUp Health, CalmStorm VC, and Deeptech Labs.